SCYNEXIS (SCYX)
(Delayed Data from NSDQ)
$0.73 USD
+0.02 (3.24%)
Updated Aug 6, 2025 04:00 PM ET
After-Market: $0.73 0.00 (-0.27%) 7:12 PM ET
3-Hold of 5 3
C Value C Growth D Momentum D VGM
Fundamental Charts
About Market Cap
As of the previous market close, SCYNEXIS, Inc. has a market cap of $27.67M, which represents its share price of $0.71 multiplied by its outstanding shares number of 39.02M. As a small-cap company, SCYX's shareholders are generally exposed to more risk than shareholders of mid and large-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
SCYX 0.73 +0.02(3.24%)
Will SCYX be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for SCYX based on the 1-3 month trading system that more than doubles the S&P 500.
Other News for SCYX
SCYNEXIS Faces Nasdaq Delisting Notice for Stock Price
SCYNEXIS: Positive Developments and Financial Stability Justify Buy Rating
SCYNEXIS Resumes Patient Dosing in Phase 3 MARIO Study | SCYX Stock News
Scynexis resumes patient dosing in Phase 3 MARIO study
SCYNEXIS: Buy Rating Affirmed Amid Strategic Advancements and Promising Antifungal Innovations